Article thumbnail

Simultaneous incorporation of the protease inhibitor nelfinavir (Nel) and bryostatin-2 (Bry) into the lipid nanoparticles (LNP-Bry-Nel) can both activate latent virus expression and inhibit viral spread.

By Michael Kovochich (353622), Matthew D. Marsden (353625) and Jerome A. Zack (198037)


<p>(A) CEM cells were infected with HIV<sub>NL4-3</sub> and the cells were incubated for 3 days in the presence of various drug combinations including LNP-Bry-Nel. Viral p24 protein in the culture supernatant was measured by ELISA. (B) LNP-Bry-Nel was further tested for its ability to activate latent virus in J-Lat 10.6 cells as measured by induction of GFP expression. Error bars indicate the standard deviation of triplicate data points and are representative of at least 2 experiments. Media represents untreated infected cultures and LNP-con represents non-drug loaded nanoparticles.</p

Topics: Pharmacology, Biotechnology, Infectious Diseases, Virology, incorporation, protease, inhibitor, nelfinavir, bryostatin-2, lipid, nanoparticles, activate, latent, inhibit, viral
Year: 2013
DOI identifier: 10.1371/journal.pone.0018270.g003
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.